[多肌痛类风湿症-老年病学中的挑战:诊断和治疗的跨学科介绍]
W Hofmann1,2, I Kötter3,4, S Winterhalter5
1, An den Uferwiesen 6, 17248, Rechlin/Müritz, Deutschland. wehofek@web.de.
Zeitschrift fur Rheumatologie
|January 29, 2024
概括
多发性肌痛风湿症 (PMR) 是老年人常见的炎症状况,导致疼痛和硬. 有效的管理涉及葡萄糖皮质类药物,可能与甲醇或生物药物,如托西利祖马布,和仔细监测.
科学领域:
- 类风湿病学 类风湿病学
- 老年病的医生 老年病的医生
- 内部医学 内部医学
背景情况:
- 多发性肌痛性风湿症 (PMR) 是50岁以上人群中第二常见的炎症性风湿性疾病.
- PMR呈现出肩膀,部和部的疼痛和早晨硬.
- 巨细胞动脉炎 (GCA) 是一个潜在的相关条件.
研究的目的:
- 概述多发性肌痛风湿症不可或缺的治疗策略.
- 讨论葡萄糖皮质类药物,甲醇和生物制剂在PMR管理中的作用.
- 强调PMR患者全面监测和老年学评估的重要性.
主要方法:
- 审查目前PMR的治疗指南和治疗选择.
- 讨论辅助疗法,包括甲醇和生物药物 (托西利祖马布,塞库金乌马布).
- 强调监测炎症标志物,副作用和功能状态的必要性.
主要成果:
- 葡萄糖皮质类药物对于PMR治疗至关重要,通常需要长期使用 (>1年).
- 可以添加甲托雷克萨特来降低葡萄糖皮质激素剂量.
- 托西利祖马布和塞库金乌马布等生物药物显示出作为替代治疗方法的希望.
结论:
- 长期的葡萄糖皮质激素治疗是PMR的标准,有减轻剂量和副作用的选择.
- 甲基和生物药物为节省葡萄糖皮质醇和改善结果提供了有价值的替代品.
- 综合的患者监测,包括功能评估和老年评估,对于最佳的PMR管理至关重要.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Myasthenia Gravis: Diagnostic Tests
844
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
844
Alzheimer's Disease: Treatment
193
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
193
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334


